Farmaceutica Remedia (BSE:RMAH) Cyclically Adjusted Book per Share: lei0.70 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:RMAH Farmaceutica Remedia SA BSE:RMAH
58 GF Score
Price lei0.87
GF Value lei0.79
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Farmaceutica Remedia Cyclically Adjusted Book per Share?

Farmaceutica Remedia BSE:RMAH +0.23% 58 Cyclically Adjusted Book per Share is lei0.70 as of Mar. 2026. GuruFocus rates BSE:RMAH with a GF Score™ of 58/100 and a GF Value™ of lei0.79 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Farmaceutica Remedia's adjusted book value per share for the three months ended in Mar. 2026 was lei0.854. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is lei0.70 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Farmaceutica Remedia was 8.00% per year. The lowest was 6.70% per year. And the median was 7.35% per year.

As of today (2026-07-18), Farmaceutica Remedia's current stock price is lei0.87. Farmaceutica Remedia's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was lei0.70. Farmaceutica Remedia's Cyclically Adjusted PB Ratio of today is 1.24.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Farmaceutica Remedia was 1.69. The lowest was 0.94. And the median was 1.17.


Farmaceutica Remedia  (BSE:RMAH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Farmaceutica Remedia's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.87/0.70
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Farmaceutica Remedia was 1.69. The lowest was 0.94. And the median was 1.17.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Farmaceutica Remedia Cyclically Adjusted Book per Share Related Terms


Farmaceutica Remedia Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Farmaceutica Remedia's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmaceutica Remedia Cyclically Adjusted Book per Share Chart

Farmaceutica Remedia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.56 0.60 0.63 0.68

Farmaceutica Remedia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.66 0.67 0.68 0.70

BSE:RMAH vs MCK, CAH, COR: Cyclically Adjusted Book per Share Comparison

For the Medical Distribution subindustry, Farmaceutica Remedia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmaceutica Remedia Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Cyclically Adjusted PB Ratio falls into.


BSE:RMAH
58GF Score
Farmaceutica Remedia SA BSE:RMAH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Farmaceutica Remedia Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Farmaceutica Remedia's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.854/330.2130*330.2130
=0.854

Current CPI (Mar. 2026) = 330.2130.

Farmaceutica Remedia Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.374 241.018 0.512
201609 0.375 241.428 0.513
201612 0.386 241.432 0.528
201703 0.397 243.801 0.538
201706 0.393 244.955 0.530
201709 0.408 246.819 0.546
201712 0.422 246.524 0.565
201803 0.443 249.554 0.586
201806 0.435 251.989 0.570
201809 0.436 252.439 0.570
201812 0.440 251.233 0.578
201903 0.448 254.202 0.582
201906 0.444 256.143 0.572
201909 0.441 256.759 0.567
201912 0.464 256.974 0.596
202003 0.455 258.115 0.582
202006 0.401 257.797 0.514
202009 0.709 260.280 0.899
202012 0.755 260.474 0.957
202103 0.718 264.877 0.895
202106 0.655 271.696 0.796
202109 0.677 274.310 0.815
202112 0.717 278.802 0.849
202203 0.691 287.504 0.794
202206 0.669 296.311 0.746
202209 0.698 296.808 0.777
202212 0.719 296.797 0.800
202303 0.716 301.836 0.783
202306 0.661 305.109 0.715
202309 0.700 307.789 0.751
202312 0.744 306.746 0.801
202403 0.750 312.332 0.793
202406 0.675 314.175 0.709
202409 0.703 315.301 0.736
202412 0.781 315.605 0.817
202503 0.000 319.799 0.000
202506 0.777 322.561 0.795
202509 0.794 324.800 0.807
202512 0.850 324.054 0.866
202603 0.854 330.213 0.854

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of lei0.70 mean?
Farmaceutica Remedia (BSE:RMAH) has a Cyclically Adjusted Book per Share of lei0.70 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Farmaceutica Remedia and its competitors.
Is Farmaceutica Remedia's Cyclically Adjusted Book per Share too high?
Farmaceutica Remedia's current Cyclically Adjusted Book per Share is lei0.70. Overall, Farmaceutica Remedia has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Farmaceutica Remedia's Cyclically Adjusted Book per Share compare to MCK and CAH?
Farmaceutica Remedia's Cyclically Adjusted Book per Share of lei0.70 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Distribution company?
A good Cyclically Adjusted Book per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Farmaceutica Remedia and its competitors. Farmaceutica Remedia's current Cyclically Adjusted Book per Share is lei0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmaceutica Remedia stock overvalued right now?
Based on GuruFocus' analysis, Farmaceutica Remedia (BSE:RMAH) is currently considered Fairly Valued. The stock's GF Value™ is lei0.79, compared to a current price of lei0.87 — trading 10.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is lei0.70. Farmaceutica Remedia's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Farmaceutica Remedia (BSE:RMAH), the current Cyclically Adjusted Book per Share is lei0.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Farmaceutica Remedia (BSE:RMAH) Overvalued in 2026?

Based on GuruFocus' analysis, Farmaceutica Remedia stock appears to be overvalued. The current stock price of lei0.87 is trading 10.1% above its estimated GF Value™ of lei0.79. GuruFocus considers Farmaceutica Remedia to be Fairly Valued.

Key valuation signals for BSE:RMAH:

  • Cyclically Adjusted Book per Share: lei0.70
  • GF Value™: lei0.79 vs. price of lei0.87 (10.1% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the BSE:RMAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Farmaceutica Remedia Business Description

Address No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
58GF Score

Get the complete analysis for BSE:RMAH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.87
Price
lei0.79
GF Value